R01MD019189
Project Grant
Overview
Grant Description
Comparing a novel telehealth-enabled hybrid cardiac rehabilitation program to clinic-based cardiac rehabilitation for improving patient engagement, functional outcomes, and health equity after ACS - Project abstract
Cardiac rehabilitation (CR)—which involves exercise training, patient education, and health behavior modification—is a comprehensive intervention traditionally delivered in clinic-based settings, with the highest recommendation and level of evidence classification (i.e., Class I, Level A) for secondary prevention.
Traditional CR significantly reduces rates of reinfarction (by 47%) and both cardiac (36%) and all-cause mortality (26%) in acute coronary syndrome (ACS) survivors, an extremely sedentary population whose functional status and health-related quality of life (HRQOL) improve after CR participation.
Despite the well-established effectiveness of traditional CR—benefits achieved through continued program participation (i.e., adherence), fewer than 10% of eligible ACS patients in the US who initiate CR (<30%) attend all prescribed CR sessions, with even lower rates among racial and ethnic minoritized groups.
Dismal participation in traditional CR programs and stark utilization disparities that have endured for decades highlight the need to design nontraditional CR models (e.g., virtual, hybrid) and rigorously test whether such models can deliver the same quality of traditional CR while equitably improving patient participation among diverse groups of cardiac patients.
To address this need, our group combined user-centered design (UCD) and implementation science (IMS) principles and methods to design and test the feasibility of a telehealth-enhanced hybrid CR program (TeleHeartCR; mixture of in-person, clinic and virtual, home sessions with a telehealth platform that supports real-time monitoring and electronic health record [EHR] data integration).
This program targets patient-, provider-, and system-level barriers in a large hospital setting that serves diverse patients.
Now, we propose to conduct a single-site, single-blind, two-arm, parallel group, randomized controlled trial to determine the degree to which TeleHeartCR equitably improves CR participation and clinical outcomes relative to traditional CR among ACS patients.
We hypothesize that participants allocated to TeleHeartCR will demonstrate greater program adherence (% of CR sessions completed) and non-inferior functional capacity (pre-to-post program change in six-minute walk test [6MWT] distance) vs participants allocated to traditional CR.
Both CR programs include 24 CR sessions over 3 months.
Program attendance, and a 6MWT at baseline and program completion, will be collected and extracted from the EHR.
Self-reported program acceptability, appropriateness, and HRQOL will be secondary outcomes.
We will also explore the comparative costs and cost-effectiveness (TeleHeartCR vs. traditional CR), as well as whether racially, ethnically, and socioeconomically minoritized groups particularly benefit.
Findings will inform the design and implementation of innovative hybrid delivery models to achieve equitable utilization of established interventions in hospital settings that serve diverse patients.
More broadly, if our hypotheses are supported, this study will illustrate the power of UCD and IMS to deploy technology in the service of closing evidence-to-practice gaps and reducing disparities in healthcare access and persistence.
Cardiac rehabilitation (CR)—which involves exercise training, patient education, and health behavior modification—is a comprehensive intervention traditionally delivered in clinic-based settings, with the highest recommendation and level of evidence classification (i.e., Class I, Level A) for secondary prevention.
Traditional CR significantly reduces rates of reinfarction (by 47%) and both cardiac (36%) and all-cause mortality (26%) in acute coronary syndrome (ACS) survivors, an extremely sedentary population whose functional status and health-related quality of life (HRQOL) improve after CR participation.
Despite the well-established effectiveness of traditional CR—benefits achieved through continued program participation (i.e., adherence), fewer than 10% of eligible ACS patients in the US who initiate CR (<30%) attend all prescribed CR sessions, with even lower rates among racial and ethnic minoritized groups.
Dismal participation in traditional CR programs and stark utilization disparities that have endured for decades highlight the need to design nontraditional CR models (e.g., virtual, hybrid) and rigorously test whether such models can deliver the same quality of traditional CR while equitably improving patient participation among diverse groups of cardiac patients.
To address this need, our group combined user-centered design (UCD) and implementation science (IMS) principles and methods to design and test the feasibility of a telehealth-enhanced hybrid CR program (TeleHeartCR; mixture of in-person, clinic and virtual, home sessions with a telehealth platform that supports real-time monitoring and electronic health record [EHR] data integration).
This program targets patient-, provider-, and system-level barriers in a large hospital setting that serves diverse patients.
Now, we propose to conduct a single-site, single-blind, two-arm, parallel group, randomized controlled trial to determine the degree to which TeleHeartCR equitably improves CR participation and clinical outcomes relative to traditional CR among ACS patients.
We hypothesize that participants allocated to TeleHeartCR will demonstrate greater program adherence (% of CR sessions completed) and non-inferior functional capacity (pre-to-post program change in six-minute walk test [6MWT] distance) vs participants allocated to traditional CR.
Both CR programs include 24 CR sessions over 3 months.
Program attendance, and a 6MWT at baseline and program completion, will be collected and extracted from the EHR.
Self-reported program acceptability, appropriateness, and HRQOL will be secondary outcomes.
We will also explore the comparative costs and cost-effectiveness (TeleHeartCR vs. traditional CR), as well as whether racially, ethnically, and socioeconomically minoritized groups particularly benefit.
Findings will inform the design and implementation of innovative hybrid delivery models to achieve equitable utilization of established interventions in hospital settings that serve diverse patients.
More broadly, if our hypotheses are supported, this study will illustrate the power of UCD and IMS to deploy technology in the service of closing evidence-to-practice gaps and reducing disparities in healthcare access and persistence.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100323720
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 380% from $821,694 to $3,943,721.
The Trustees Of Columbia University In The City Of New York was awarded
TeleHeartCR vs. Traditional CR for ACS Patients
Project Grant R01MD019189
worth $3,943,721
from National Institute for Minority Health and Health Disparities in September 2024 with work to be completed primarily in New York New York United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.307 Minority Health and Health Disparities Research.
The Project Grant was awarded through grant opportunity Research Project Grant (Parent R01 Clinical Trial Required).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
9/20/24
Start Date
5/31/29
End Date
Funding Split
$3.9M
Federal Obligation
$0.0
Non-Federal Obligation
$3.9M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01MD019189
Additional Detail
Award ID FAIN
R01MD019189
SAI Number
R01MD019189-2408590215
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NE00 NIH National Insitute on Minority Health and Healh Disparities
Funding Office
75NE00 NIH National Insitute on Minority Health and Healh Disparities
Awardee UEI
QHF5ZZ114M72
Awardee CAGE
3FHD3
Performance District
NY-13
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 6/22/26